{"altmetric_id":24543155,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":6},"twitter":{"unique_users_count":6,"unique_users":["PPSChicago","BioMedCentral","HAS_veille","NCad_Nederland","bhas_dr","IssaBihi"],"posts_count":6}},"selected_quotes":["Safety and effectiveness of #StemCell therapies in early-phase clinical #trials in #stroke","Safety effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review"],"citation":{"abstract":"Stem cells have demonstrated encouraging potential as reparative therapy for patients suffering from post-stroke disability. Reperfusion interventions in the acute phase of stroke have shown significant benefit but are limited by a narrow window of opportunity in which they are beneficial. Thereafter, rehabilitation is the only intervention available. The current review summarises the current evidence for use of stem cell therapies in stroke from early-phase clinical trials. The safety and feasibility of administering different types of stem cell therapies in stroke seem to be reasonably proven. However, the effectiveness needs still to be established through bigger clinical trials with more pragmatic clinical trial designs that address the challenges raised by the heterogeneous nature of stroke per se, as well those due to unique characteristics of stem cells as therapeutic agents.","altmetric_jid":"4f6fa4d03cf058f6100008b6","authors":["Anjali Nagpal","Fong Chan Choy","Stuart Howell","Susan Hillier","Fiona Chan","Monica A. Hamilton-Bruce","Simon A. Koblar"],"doi":"10.1186\/s13287-017-0643-x","first_seen_on":"2017-08-30T22:01:15+00:00","funders":["niehs"],"handles":[],"issns":["1757-6512"],"issue":"1","journal":"Stem Cell Research & Therapy","last_mentioned_on":1505140354,"links":["https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-017-0643-x","https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-017-0643-x?sf111291795=1"],"pdf_url":"https:\/\/stemcellres.biomedcentral.com\/track\/pdf\/10.1186\/s13287-017-0643-x?site=stemcellres.biomedcentral.com","pmid":"28854961","pubdate":"2017-08-30T00:00:00+00:00","publisher":"BioMed Central","publisher_subjects":[{"name":"Technology","scheme":"era"},{"name":"Biological Sciences","scheme":"era"},{"name":"Medical And Health Sciences","scheme":"era"}],"startpage":"191","subjects":["cellbiology"],"title":"Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis","type":"article","volume":"8","mendeley_url":"http:\/\/www.mendeley.com\/research\/safety-effectiveness-stem-cell-therapies-earlyphase-clinical-trials-stroke-systematic-review-metaana"},"altmetric_score":{"score":2.85,"score_history":{"1y":2.85,"6m":2.85,"3m":2.85,"1m":2.85,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.85},"context_for_score":{"all":{"total_number_of_other_articles":8397236,"mean":7.0723276090205,"rank":3314106,"this_scored_higher_than_pct":60,"this_scored_higher_than":5046637,"rank_type":"exact","sample_size":8397236,"percentile":60},"similar_age_3m":{"total_number_of_other_articles":144239,"mean":12.469388455192,"rank":46760,"this_scored_higher_than_pct":66,"this_scored_higher_than":96455,"rank_type":"exact","sample_size":144239,"percentile":66},"this_journal":{"total_number_of_other_articles":680,"mean":4.9569160530191,"rank":243,"this_scored_higher_than_pct":63,"this_scored_higher_than":433,"rank_type":"exact","sample_size":680,"percentile":63},"similar_age_this_journal_3m":{"total_number_of_other_articles":25,"mean":1.5833333333333,"rank":4,"this_scored_higher_than_pct":84,"this_scored_higher_than":21,"rank_type":"exact","sample_size":25,"percentile":84}}},"demographics":{"poster_types":{"member_of_the_public":5,"researcher":1},"users":{"twitter":{"cohorts":{"Members of the public":5,"Scientists":1}},"mendeley":{"by_status":{"Unspecified":1,"Student  > Ph. D. Student":1,"Lecturer > Senior Lecturer":1},"by_discipline":{"Medicine and Dentistry":1,"Agricultural and Biological Sciences":1,"Unspecified":1}}},"geo":{"twitter":{"US":1,"GB":1,"SE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/PPSChicago\/statuses\/903014725402992640","license":"gnip","citation_ids":[24543155],"posted_on":"2017-08-30T22:01:02+00:00","author":{"name":"Premier Pain","url":"http:\/\/ppschicago.com","image":"https:\/\/pbs.twimg.com\/profile_images\/727608347067736065\/bVVPE28O_normal.jpg","description":"Chicago's fastest growing, largest fully fellowship-trained and doubled-boarded Multidisciplinary Pain Practice with 7 locations. #ppschicago #nopain","id_on_source":"PPSChicago","tweeter_id":"2342639810","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":200},"tweet_id":"903014725402992640"},{"url":"http:\/\/twitter.com\/BioMedCentral\/statuses\/904645268745879552","license":"gnip","citation_ids":[24543155],"posted_on":"2017-09-04T10:00:14+00:00","author":{"name":"BMC","url":"http:\/\/www.biomedcentral.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/888016438174339073\/foekpiRD_normal.jpg","description":"A pioneer of sustainable open access, where research is always in progress. Tweets by @DannoCaley","id_on_source":"BioMedCentral","tweeter_id":"41561657","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":47532},"tweet_id":"904645268745879552"},{"url":"http:\/\/twitter.com\/HAS_veille\/statuses\/904646588521480196","license":"gnip","rt":["BioMedCentral"],"citation_ids":[24543155],"posted_on":"2017-09-04T10:05:28+00:00","author":{"name":"HAS-veille","image":"https:\/\/pbs.twimg.com\/profile_images\/605737276690317312\/S1pSJg1a_normal.jpg","description":"Veille documentaire des services Doc & Presse de la HAS. Choses vues et lues int\u00e9ressantes \u00e0 conna\u00eetre.  A ne pas confondre avec les positions de la HAS","id_on_source":"HAS_veille","tweeter_id":"3306558887","geo":{"lt":null,"ln":null},"followers":963},"tweet_id":"904646588521480196"},{"url":"http:\/\/twitter.com\/NCad_Nederland\/statuses\/904647715904258048","license":"gnip","rt":["BioMedCentral"],"citation_ids":[24543155],"posted_on":"2017-09-04T10:09:57+00:00","author":{"name":"NCad","url":"http:\/\/www.ncadierproevenbeleid.nl","image":"https:\/\/pbs.twimg.com\/profile_images\/596252044920496128\/5KMTC_wq_normal.jpg","description":"Het NCad voor bescherming van dieren die worden gebruikt voor wetenschappelijke doeleinden en onderwijs. Uitgangspunt: Vervangen, Verminderen, Verfijnen (3V's).","id_on_source":"NCad_Nederland","tweeter_id":"2966021271","geo":{"lt":null,"ln":null},"followers":148},"tweet_id":"904647715904258048"},{"url":"http:\/\/twitter.com\/bhas_dr\/statuses\/904688909984055299","license":"gnip","rt":["BioMedCentral"],"citation_ids":[24543155],"posted_on":"2017-09-04T12:53:39+00:00","author":{"name":"DrGeethanjaliBhas,MD","image":"https:\/\/pbs.twimg.com\/profile_images\/778226429724987396\/XxeHRyJD_normal.jpg","description":"Professor(assoc) IMS,MSU #  MD,DNB, MBA, PATHOLOGIST # Member RCPath(UK ),DPA,KCIAPM #creative teaching # KNOWLEDGE SHARING # digital pathology #future medicine","id_on_source":"bhas_dr","tweeter_id":"4327691963","geo":{"lt":null,"ln":null},"followers":899},"tweet_id":"904688909984055299"},{"url":"http:\/\/twitter.com\/IssaBihi\/statuses\/907250517906161664","license":"gnip","citation_ids":[24543155],"posted_on":"2017-09-11T14:32:34+00:00","author":{"name":"Issa Bihi","url":"http:\/\/clinicalneuropsychologyblog.blogspot.se","image":"https:\/\/pbs.twimg.com\/profile_images\/703902293587001344\/qTz0rSjX_normal.jpg","description":"Fritidspolitiker (M). Far till tre. Twittering interests in Neuroscience & political economy - @IssaHBihi","id_on_source":"IssaBihi","tweeter_id":"361361273","geo":{"lt":62,"ln":15,"country":"SE"},"followers":129},"tweet_id":"907250517906161664"}]}}